Oral contraceptive use and risk of fractures

被引:23
|
作者
Vestergaard, Peter [1 ]
Rejnmark, Lars [1 ]
Mosekilde, Leif [1 ]
机构
[1] Aarhus Univ Hosp, Osteoporosis Clin, Aarhus Amtssygehus, Dept Endocrinol & Metab C, DK-8000 Aarhus C, Denmark
关键词
fracture; oral contraceptives; epidemiology; risk factors; confounders;
D O I
10.1016/j.contraception.2006.01.006
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Introduction: Prior studies have suggested that oral contraceptives (OCs) may be associated with an increased fracture risk. However, the previous studies have only performed a limited adjustment for other potential risk factors. Subjects and Methods: All women with a fracture (n=64,548) in the year 2000 in Denmark served as cases. For each case, three age-matched controls were randomly drawn from the general population (n = 193,641). Exposure was use of OCs between January 1, 1996, and December 31, 2000. Adjustments were made for use of other drugs, pregnancy, prior fracture, other diseases and social variables. Results: In the unadjusted analysis, use of OCs in low dose was associated with a small increase in overall fracture risk. However, upon adjustment, no increase in fracture risk could be demonstrated in any age or dose group. Conclusion: Oral contraceptives are not associated with an increase or a decrease in fracture risk. Any change in fracture risk may be due to confounders. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:571 / 576
页数:6
相关论文
共 50 条
  • [21] Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review
    Bovo, Adriane Cristina
    Pedrao, Priscila Grecca
    Guimaraes, Yasmin Medeiros
    Godoy, Luani Rezende
    Resende, Julio Cesar Possati
    Longatto-Filho, Adhemar
    dos Reis, Ricardo
    REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA, 2023, 45 (12): : E818 - E823
  • [22] Timing of births and oral contraceptive use influences ovarian cancer risk
    Wu, Anna H.
    Pearce, Celeste Leigh
    Lee, Alice W.
    Tseng, Chiuchen
    Jotwani, Anjali
    Patel, Prusha
    Pike, Malcolm C.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (12) : 2392 - 2399
  • [23] Duration of oral contraceptive use and the risk of venous thromboembolism. A case-control study
    Martinelli, Ida
    Maino, Alberto
    Abbattista, Maria
    Bucciarelli, Paolo
    Passamonti, Serena M.
    Artoni, Andrea
    Gianniello, Francesca
    Peyvandi, Flora
    THROMBOSIS RESEARCH, 2016, 141 : 153 - 157
  • [24] Influence of oral contraceptive use on the risk of adult-onset vulvodynia
    Harlow, Bernard L.
    Vitonis, Allison E.
    Stewart, Elizabeth Gunther
    JOURNAL OF REPRODUCTIVE MEDICINE, 2008, 53 (02) : 102 - 110
  • [25] Oral contraceptive use and risk of breast carcinoma in situ (United States)
    Jasmeet K. Gill
    Michael F. Press
    Alpa V. Patel
    Leslie Bernstein
    Cancer Causes & Control, 2006, 17 : 1155 - 1162
  • [26] ORAL-CONTRACEPTIVE USE AND THE RISK OF INFLAMMATORY BOWEL-DISEASE
    SANDLER, RS
    WURZELMANN, JI
    LYLES, CM
    EPIDEMIOLOGY, 1992, 3 (04) : 374 - 378
  • [27] Recent oral contraceptive use and risk of breast cancer (United States)
    Newcomb, PA
    Longnecker, MP
    Storer, BE
    Mittendorf, R
    Baron, J
    Clapp, RW
    TrenthamDietz, A
    Willett, WC
    CANCER CAUSES & CONTROL, 1996, 7 (05) : 525 - 532
  • [28] ORAL-CONTRACEPTIVE USE AND CORONARY RISK-FACTORS IN WOMEN
    LEAF, DA
    BLAND, D
    SCHAAD, D
    NEIGHBOR, WE
    SCOTT, CS
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1991, 301 (06) : 365 - 368
  • [29] Oral contraceptive use and risk of breast carcinoma in situ (United States)
    Gill, Jasmeet K.
    Press, Michael F.
    Patel, Alpa V.
    Bernstein, Leslie
    CANCER CAUSES & CONTROL, 2006, 17 (09) : 1155 - 1162
  • [30] Association between oral contraceptive use and pancreatic cancer risk: A systematic review and meta-analysis
    Ilic, Milena
    Milicic, Biljana
    Ilic, Irena
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (20) : 2643 - 2656